Congenital Lung Anomalies (CLA) Swiss Database
Launched by UNIVERSITY HOSPITAL, GENEVA · Feb 2, 2017
Trial Information
Current as of July 14, 2025
Recruiting
Keywords
ClinConnect Summary
The Congenital Lung Anomalies (CLA) Swiss Database trial is studying different types of lung problems that some babies are born with, such as cysts and other malformations. These conditions are quite rare, affecting less than 1 in 10,000 births, and researchers are trying to understand more about how they develop and how they change over time. By collecting information from various hospitals in Switzerland, the study aims to learn about the clinical and imaging features of these conditions and uncover the underlying causes.
Anyone diagnosed with congenital lung anomalies, regardless of age or gender, may be eligible to participate in the trial. There are no specific exclusions, so if you or someone you know has one of these conditions, you can be part of this important research. Participants will help researchers gather valuable data that could lead to better understanding and treatment options in the future. Your involvement could make a meaningful difference in advancing knowledge about these rare lung issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients diagnosed with congenital lung anomalies
- Exclusion Criteria:
- • None
About University Hospital, Geneva
The University Hospital of Geneva is a leading academic medical center committed to advancing healthcare through innovative research and clinical excellence. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge medical research with high-quality patient care, fostering a collaborative environment that encourages the translation of scientific discoveries into practical treatments. As a prominent sponsor of clinical trials, the University Hospital of Geneva is dedicated to exploring new therapies and improving patient outcomes, while adhering to the highest ethical standards and regulatory compliance. Its robust infrastructure and expert clinical teams ensure the efficient execution of trials across various medical specialties, contributing significantly to the advancement of global health initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Geneva, , Switzerland
Patients applied
Trial Officials
Isabelle Andrieu Vidal, MD PhD
Principal Investigator
University Hospital, Geneva
Isabelle Ruchonnet-Métrailler, MD PhD
Principal Investigator
University Hospital, Geneva
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials